Back
Altamira Therapeutics Stock Predictions
Sponsored
CYTOF
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
19
CYTOF
Altamira Therapeutics
Last Price:
$0.09
Seasonality Move:
-17.35%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--hereAltamira Therapeutics Stock Forecast
-
Is Altamira Therapeutics Stock Undervalued?The current Altamira Therapeutics [CYTOF] share price is $0.12. The Score for CYTOF is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
CYTOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Altamira Therapeutics Stock Go Up Next Year?
Data Unavailable
Altamira Therapeutics Stock Rating
Data Unavailable
Altamira Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
OTCM
Country:
Bermuda
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
altamiratherapeutics.com
52-Week Data
52-Week High:
3.60
52-Week Low:
0.10
Prediction Charts
Market Cap:
452.7K
Price in USD:
0.12
Volume:
745.1K
Beta:
1.65
Technical Analysis
SMA50:
0.47
SMA100:
0.66
SMA200:
1.09
52-Wk Change:
-95.56%
Stock Predictions
-
Is Altamira Therapeutics stock public?Yes, Altamira Therapeutics is a publicly traded company.
-
What is the Altamira Therapeutics stock quote today?The Altamira Therapeutics stock price is 0.12 USD today.
-
How to buy Altamira Therapeutics stock online?You can buy Altamira Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-3 | 0.42 | 0.48 | 0.54 | 0.42 |
Dec-4 | 0.49 | 0.46 | 0.55 | 0.45 |
Dec-5 | 0.46 | 0.49 | 0.52 | 0.45 |
Dec-6 | 0.48 | 0.52 | 0.53 | 0.47 |
Dec-9 | 0.52 | 0.49 | 0.58 | 0.45 |
Dec-10 | 0.47 | 0.46 | 0.50 | 0.44 |
Dec-11 | 0.46 | 0.47 | 0.49 | 0.43 |
Dec-12 | 0.45 | 0.46 | 0.46 | 0.43 |
Dec-13 | 0.44 | 0.43 | 0.46 | 0.43 |
Dec-16 | 0.43 | 0.42 | 0.45 | 0.42 |
Dec-17 | 0.41 | 0.41 | 0.44 | 0.40 |
Dec-18 | 0.42 | 0.41 | 0.43 | 0.40 |
Dec-19 | 0.42 | 0.30 | 0.43 | 0.30 |
Dec-20 | 0.14 | 0.12 | 0.20 | 0.10 |
Altamira Therapeutics Earnings
Data Unavailable
Altamira Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $1.76 per share.
* Altamira Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.